Skip to Main Content

Author Details

Eduardo Vilar
The University of Texas MD Anderson Cancer Center
2005
125
33
Trey Ideker (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
35195555Germline Cancer Risk Profiles of Patients With Young-Onset Colorectal Cancer: Findings From a Prospective Universal Germline Testing and Telegenetics Program.Dis Colon Rectum2023
38085001Sustained Disease Control in Immune Checkpoint Blockade Responders with Microsatellite Instability-high Colorectal Cancer after Treatment Termination.Cancer Res Commun2023
37897815Exploring Stakeholders' Perspectives on Implementing Universal Germline Testing for Colorectal Cancer: Findings From a Clinical Practice Survey.JCO Precis Oncol2023
37478804Advances in vaccine development for cancer prevention and treatment in Lynch Syndrome.Mol Aspects Med2023
37572314The Cancer Moonshot Immuno-Oncology Translational Network at 5: accelerating cancer immunotherapies.J Natl Cancer Inst2023
37724990Exercise Training Reduces the Inflammatory Response and Promotes Intestinal Mucosa-Associated Immunity in Lynch Syndrome.Clin Cancer Res2023
35636921Phase II trial of weekly erlotinib dosing to reduce duodenal polyp burden associated with familial adenomatous polyposis.Gut2023
37207208Naproxen chemoprevention induces proliferation of cytotoxic lymphocytes in Lynch Syndrome colorectal mucosa.Front Immunol2023
37403656From Premalignant Biology to Precision Interception: Connecting the Dots with a Curated Collection of Invited Articles.Cancer Prev Res (Phila)2023
37168379Colorectal surveillance outcomes from an institutional longitudinal cohort of lynch syndrome carriers.Front Oncol2023
37001882Worth a Pound of Cure? Emerging Strategies and Challenges in Cancer Immunoprevention.Cancer Prev Res (Phila)2023
37293588Current chemoprevention approaches in Lynch syndrome and Familial adenomatous polyposis: a global clinical practice survey.Front Oncol2023
36549470Delphi Initiative for Early-Onset Colorectal Cancer (DIRECt) International Management Guidelines.Clin Gastroenterol Hepatol2023
36623241Neoadjuvant Pembrolizumab in Localized Microsatellite Instability High/Deficient Mismatch Repair Solid Tumors.J Clin Oncol2023
36351210Resistance Mechanisms to Anti-Epidermal Growth Factor Receptor Therapy in <i>RAS/RAF</i> Wild-Type Colorectal Cancer Vary by Regimen and Line of Therapy.J Clin Oncol2023
34059508Chromatin state dynamics confers specific therapeutic strategies in enhancer subtypes of colorectal cancer.Gut2022
35845232Colorectal cancer during pregnancy or postpartum: Case series and literature review.Obstet Med2022
35502553Lessons Learned from the Impact of COVID-19 on NCI-sponsored Cancer Prevention Clinical Trials: Moving Toward Participant-centric Study Designs.Cancer Prev Res (Phila)2022
35688320Loss of MMR and TGFBR2 Increases the Susceptibility to Microbiota-Dependent Inflammation-Associated Colon Cancer.Cell Mol Gastroenterol Hepatol2022
35687697ATR-mediated CD47 and PD-L1 up-regulation restricts radiotherapy-induced immune priming and abscopal responses in colorectal cancer.Sci Immunol2022
35446842Comparative molecular genomic analyses of a spontaneous rhesus macaque model of mismatch repair-deficient colorectal cancer.PLoS Genet2022
36239938Association of Prediagnosis Obesity and Postdiagnosis Aspirin With Survival From Stage IV Colorectal Cancer.JAMA Netw Open2022
35987446Clinically Significant Metachronous Colorectal Pathology Detected Among Young-Onset Colorectal Cancer Survivors: Implications for Post-Resection Surveillance Guidelines.Gastroenterology2022
36007963Phase II study of durvalumab (anti-PD-L1) and trametinib (MEKi) in microsatellite stable (MSS) metastatic colorectal cancer (mCRC).J Immunother Cancer2022
36047056Can a Banana a Day Keep the Cancer Away in Patients with Lynch Syndrome?Cancer Prev Res (Phila)2022
34983369Sensei: how many samples to tell a change in cell type abundance?BMC Bioinformatics2022
35218578Patterns of germline and somatic testing after universal tumor screening for Lynch syndrome: A clinical practice survey of active members of the Collaborative Group of the Americas on Inherited Gastrointestinal Cancer.J Genet Couns2022
34971795Optimization of an mHealth lifestyle intervention for families with hereditary cancer syndromes: Study protocol for a multiphase optimization strategy feasibility study.Contemp Clin Trials2022
34993941Transcriptomic-Assisted Immune and Neoantigen Profiling in Premalignancy.Methods Mol Biol2022
32641470Naproxen chemoprevention promotes immune activation in Lynch syndrome colorectal mucosa.Gut2021
33842408Meeting Report: Translational Advances in Cancer Prevention Agent Development Meeting.J Cancer Prev2021
34224739Recurrent Frameshift Neoantigen Vaccine Elicits Protective Immunity With Reduced Tumor Burden and Improved Overall Survival in a Lynch Syndrome Mouse Model.Gastroenterology2021
34266857Combination of Sulindac and Bexarotene for Prevention of Intestinal Carcinogenesis in Familial Adenomatous Polyposis.Cancer Prev Res (Phila)2021
34003775The Transcriptomic Landscape of Mismatch Repair-Deficient Intestinal Stem Cells.Cancer Res2021
34253611Telomere dysfunction instigates inflammation in inflammatory bowel disease.Proc Natl Acad Sci U S A2021
31972642Comment on "A National Cancer Database Analysis of Microsatellite Instability and Pathologic Complete Response in Locally Advanced Rectal Cancer".Ann Surg2021
33229221Epidemiology and Molecular-Pathologic Characteristics of CpG Island Methylator Phenotype (CIMP) in Colorectal Cancer.Clin Colorectal Cancer2021
33277315Optimization of Erlotinib Plus Sulindac Dosing Regimens for Intestinal Cancer Prevention in an Apc-Mutant Model of Familial Adenomatous Polyposis (FAP).Cancer Prev Res (Phila)2021
33208919The prognostic impact of RAS on overall survival following liver resection in early versus late-onset colorectal cancer patients.Br J Cancer2021
31383734Immune Activation in Mismatch Repair-Deficient Carcinogenesis: More Than Just Mutational Rate.Clin Cancer Res2020
31896172Somatic mismatch repair testing in evaluation of Lynch syndrome: The gap between preferred and current practices.J Genet Couns2020
31685958Large-scale analysis of acquired chromosomal alterations in non-tumor samples from patients with cancer.Nat Biotechnol2020
32008976Patient-reported Symptom Outcomes and Microsatellite Instability in Patients With Metastatic Colorectal Cancer.Clin Colorectal Cancer2020
33037026Precision Prevention and Cancer Interception: The New Challenges of Liquid Biopsy.Cancer Discov2020
32958778Telomere dysfunction activates YAP1 to drive tissue inflammation.Nat Commun2020
32554617Cancer Moonshot Immuno-Oncology Translational Network (IOTN): accelerating the clinical translation of basic discoveries for improving immunotherapy and immunoprevention of cancer.J Immunother Cancer2020
32525015AGA Clinical Practice Update on Young Adult-Onset Colorectal Cancer Diagnosis and Management: Expert Review.Clin Gastroenterol Hepatol2020
32545271Relative Abundance of SARS-CoV-2 Entry Genes in the Enterocytes of the Lower Gastrointestinal Tract.Genes (Basel)2020
30584801Genetic predisposition to colorectal cancer: syndromes, genes, classification of genetic variants and implications for precision medicine.J Pathol2019
32914034Atypical, Non-V600 BRAF Mutations as a Potential Mechanism of Resistance to EGFR Inhibition in Metastatic Colorectal Cancer.JCO Precis Oncol2019
  • 1 - 50 of 125

Recommended Authors

Walid K Chatila
Memorial Sloan Kettering Cancer Center
Career Start Year 2017
Number of shared co-authors 5
Daniela Hirsch
Institute of Pathology, University Medical Center Mannheim, University of Heidelberg
Career Start Year 2012
Number of shared co-authors 1
Salvatore Piscuoglio
University of Basel
Career Start Year 2008
Number of shared co-authors 0
Barry S Taylor
Memorial Sloan Kettering Cancer Center
Career Start Year 2006
Number of shared co-authors 6
Louis Vermeulen
Oncode Institute
Career Start Year 2006
Number of shared co-authors 5
Claire Palles
Institute of Cancer and Genomic Sciences, University of Birmingham
Career Start Year 2006
Number of shared co-authors 1
Katia Nones
QIMR Berghofer Medical Research Institute
Career Start Year 2006
Number of shared co-authors 2
Jamie K Teer
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year 2005
Number of shared co-authors 3
Albrecht Stenzinger
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2005
Number of shared co-authors 5
Kurt W Fisher
University of Nebraska Medical Center
Career Start Year 2004
Number of shared co-authors 1
Nikolaus Schultz
Memorial Sloan Kettering Cancer Center
Career Start Year 2003
Number of shared co-authors 17
Olivier Harismendy
University of California
Career Start Year 2003
Number of shared co-authors 7
Daniel L Worthley
South Australian Health and Medical Research Institute
Career Start Year 2001
Number of shared co-authors 1
Colin C Pritchard
University of Washington, USA Brotman Baty Institute for Precision Medicine
Career Start Year 1999
Number of shared co-authors 6
Tobias Sj??blom
Uppsala University
Career Start Year 1999
Number of shared co-authors 1
Robert Gryfe
University of Toronto
Career Start Year 1997
Number of shared co-authors 1
William M Grady
. Fred Hutchinson Cancer Center
Career Start Year 1997
Number of shared co-authors 6
Charles Swanton
Francis Crick Institute
Career Start Year 1997
Number of shared co-authors 16
Manon van Engeland
Maastricht University Medical Center
Career Start Year 1996
Number of shared co-authors 0
Remond J A Fijneman
The Netherlands Cancer Institute
Career Start Year 1993
Number of shared co-authors 0
Gerrit A Meijer
The Netherlands Cancer Institute
Career Start Year 1992
Number of shared co-authors 3
Paul T Fanta
University of California San Diego Moores Cancer Center
Career Start Year 1992
Number of shared co-authors 7
Levi A Garraway
Broad Institute of Harvard and MIT
Career Start Year 1991
Number of shared co-authors 13
Nicholas J Hawkins
School of Public Health, Imperial College London
Career Start Year 1990
Number of shared co-authors 1
Aaron Pollett
Mount Sinai Hospital
Career Start Year 1990
Number of shared co-authors 3
James M Ford
Stanford University
Career Start Year 1989
Number of shared co-authors 7
Robyn L Ward
University of Sydney
Career Start Year 1989
Number of shared co-authors 2
Bharati Bapat
Mt Sinai Hospital
Career Start Year 1988
Number of shared co-authors 0
Katherine L Nathanson
Perelman School of Medicine, University of Pennsylvania, USA Abramson Cancer Center
Career Start Year 1986
Number of shared co-authors 13
Steven Gallinger
Lunenfeld Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto
Career Start Year 1983
Number of shared co-authors 12

Collaborators

Scott Kopetz
University of Texas MD Anderson Cancer Center
Co-authored papers 29
Ernest T Hawk
The University of Texas MD Anderson Cancer Center
Co-authored papers 12
Paul Scheet
University of Texas M.D. Anderson Cancer Center
Co-authored papers 11
Florencia McAllister
The University of Texas MD Anderson Cancer Center
Co-authored papers 6
Anirban Maitra
The University of Texas MD Anderson Cancer Center
Co-authored papers 6
Krishna M Sinha
The University of Texas MD Anderson Cancer Center
Co-authored papers 5
Jerry Fowler
The University of Texas MD Anderson Cancer Center
Co-authored papers 5
Jeffrey S Morris
Perelman School of Medicine, University of Pennsylvania
Co-authored papers 5
Funda Meric-Bernstam
University of Texas MD Anderson Cancer Center
Co-authored papers 5
Elena M Stoffel
Rogel Cancer Center, University of Michigan ann arbor
Co-authored papers 5
Powel H Brown
The University of Texas MD Anderson Cancer Center
Co-authored papers 4
Mary L Disis
University of Washington Medicine Cancer Vaccine Institute, University of Washington
Co-authored papers 4
Winfried Edelmann
Albert Einstein College of Medicine
Co-authored papers 4
Shailesh Advani
Co-authored papers 4
Jianhua Zhang
University of Texas MD Anderson Cancer Center
Co-authored papers 3
Scott M Lippman
Moores Cancer Center, university of california san diego
Co-authored papers 3
Matthew B Yurgelun
34Dana-Farber/Brigham and Women's Cancer Center.
Co-authored papers 3
Kenna R Mills Shaw
The University of Texas MD Anderson Cancer Center
Co-authored papers 3
Phillip A Futreal
The University of Texas MD Anderson Cancer Center
Co-authored papers 3
Elena Tosti
Albert Einstein College of Medicine
Co-authored papers 3
Samir M Hanash
University of Texas MD Anderson Cancer Center
Co-authored papers 3
John Paul Shen
The University of Texas MD Anderson Cancer Center
Co-authored papers 3
Timothy R Rebbeck
Center for Cancer Equity and Engagement, Dana-Farber/Harvard Cancer Center
Co-authored papers 3
Lawrence Fong
University of California san francisco
Co-authored papers 2
Ganiraju C Manyam
the University of Texas MD Anderson Cancer Center
Co-authored papers 2
Gordon B Mills
Knight Cancer Institute, Oregon Health and Sciences University
Co-authored papers 2
AmirAli Talasaz
University of California San Diego Moores Cancer Center
Co-authored papers 2
Robert H Shoemaker
National Cancer Institute
Co-authored papers 2
Ken Chen
University of Texas MD Anderson Cancer Center
Co-authored papers 2
José Baselga
Co-authored papers 2
Release 1.2